Wolf Popper’s Health Care Litigation practice is backed by the Firm’s strong record in consumer fraud and complex class action litigation. As laws, reimbursement systems, and industry practices shift, health care disputes have become increasingly complex. Our team remains closely attuned to regulatory and marketplace developments to effectively protect patients, insureds, and health care consumers.
We represent individuals, benefit plan participants, and other stakeholders in health insurance litigation, drug pricing class actions, and disputes involving deceptive or improper practices by health insurers, pharmacy benefit managers (PBMs), pharmaceutical manufacturers, and health care providers. Many matters also overlap with consumer litigation when systemic practices harm large groups of consumers.
Our Health Care Litigation practice includes claims involving:
When health care misconduct creates broader financial or contractual harm, claims may align with commercial litigation and arbitration.
The health care system is constantly shifting, driven by regulatory change, insurer policies, and industry business models. These shifts can result in coverage denials, improper billing, or financial harm to patients and insureds.
Wolf Popper draws on experience in consumer protection, insurance litigation, PBM and drug pricing disputes, and class actions to hold health care industry participants accountable. In matters with market-wide impact or investor implications, the Firm’s securities litigation practice may also support related claims.
We analyze billing practices, coverage decisions, pricing structures, plan disclosures, and insurer-provider relationships to identify wrongdoing and develop a tailored litigation strategy. Our approach includes:
Our objective is to obtain meaningful relief for affected individuals and help promote fair, transparent, and lawful practices across the health care marketplace.
In addition to litigation, Wolf Popper provides advisory guidance to individuals, benefit plan participants, and organizations assessing potential health care, insurance, billing, or PBM-related claims. We monitor emerging industry patterns and regulatory trends that may signal broader consumer impact.
If you have concerns regarding health care violations, unfair insurance practices, improper billing, or coverage decisions, we welcome a conversation to assess the situation and determine the most strategic path forward.
Firm News | 03/05/2025
Firm News | 02/26/2025
Publications | 10/14/2024
Nearly $1 trillion in private equity funds have gone into almost 8,000 health care transactions over the past decade, according to KFF Health News.
Publications | 06/10/2024
Consumers often are surprised by receiving large bills for medical testing from a laboratory when they believe the testing should have been covered by their health insurance.
Publications | 04/29/2024
Firm News | 03/27/2024
A surprise medical bill is one received by an insured patient for services rendered by a health care provider, or in a medical facility, that is out-of-network to that patient's insurance plan, ...
Publications | 02/20/2024
Firm News | 11/13/2023
Case Updates | 11/08/2023
Firm News | 09/26/2023
Firm News | 05/19/2023
Events | May 10-12, 2023
Events | March 20 - 23, 2023
Events | February 15 - 17, 2023
Americans currently have $140 Billion in medical debt. It is the foremost reason for personal bankruptcy in America and the largest source of debt for American families.
Publications | 02/01/2023
Events | January 17 - 20, 2023
Events | October 23 - 26, 2022
Case Updates | 02/02/2021
Case Updates | 01/29/2021
Case Updates | 08/24/2020
Case Updates | 07/08/2020
Case Updates | 02/20/2020